Molecular epidemiology of an SHV-5 extended-spectrum ²-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit

Clinical Infectious Diseases

Volumn 21, Issue 4, 1995, Pages 915-923

  Venezia, Richard A ^a,b,c   Scarano, Frank J ^a,b,c   Preston, Karen E ^a,b,c   Steele, Lynn M ^a,b,c   Root, Timothy P ^a,b,c   Limberger, Ronald ^a,b,c   Archinal, Wendy ^a,b,c   Kacica, Marilyn A ^a,b,c  

^a ALBANY MEDICAL CENTER   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; ERYTHROMYCIN; IMIPENEM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; DNA HYBRIDIZATION; DNA SEQUENCE; HUMAN; ISOELECTRIC FOCUSING; KLEBSIELLA OXYTOCA; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CASE REPORT; CEFTAZIDIME; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CLONING, MOLECULAR; CROSS INFECTION; DISEASE OUTBREAKS; FATAL OUTCOME; GENES, BACTERIAL; HUMAN; INFANT; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; ISOELECTRIC FOCUSING; KLEBSIELLA; KLEBSIELLA INFECTIONS; PLASMIDS;

EID: 0028783813     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/21.4.915     Document Type: Article

References (37)

1. Jacoby GA, Archer GL. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991;324:601-12.
2. Jacoby GA, Medeiros AA. More extended-spectrum /9-lactamases. Antimi-crob Agents Chemother 1991;35:1697-704.
3. Maddux MS. Effects of /9-lactamase-mediated antimicrobial resistance: the roleof /3-lactamase inhibitors. Pharmacotherapy 1991; 11 (suppl 2):40S-50S.
4. Moellering RC. Meeting the challenges of /3-lactamases. J Antimicrob Chemother 1993;31(suppl A): 1-8.
5. Sanders CC, Sanders WE. /3-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992; 15:824-39.
6. Moellering RC /3-Lactamase inhibition: therapeutic implications in infectious diseases—an overview. Rev Infect Dis 1991; 13(suppl 9):S723-6.
7. Sanders CC. /3-Lactamases of gram-negative bacteria: new challenges for new drugs. Clin Infect Dis 1992;14:1089-99.
8. Urban C, Meyer KS, Mariano N, et al. Identification of TEM-26 /3-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 1994;38:392-5.
9. Philippon A, Labia R, Jacoby G. Extended-spectrum /3-lactamases. Antimicrob Agents Chemother 1989;33:1131-6.
10. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353-8.
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A4. 4th ed. Villanova, PA: National Committee for Clinical Laboratory Standards, 1990.
12. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum/3-lactamases conferring transferable resistance to newer /3-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-78.
13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A2. 2nd ed. Villanova, PA: National Committee for Clinical Laboratory Standards, 1990.
14. Schoonmaker D, Heimberger T, Birkhead G. Comparison of ribotyping and restriction enzyme analysis using pulsed-field gel electrophoresis for distinguishing Legionella pneumophila isolates obtained during a nosocomial outbreak. J Clin Microbiol 1992;30:1491-8.
15. Gouby A, Neuwirth C, Bourg G, et al. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum /3-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994;32:301-5.
16. Maslow JN, Slutsky AM, Arbeit RD. Application of pulsed-field gelelectrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington, DC: American Society for Microbiology, 1993:563-72.
17. Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analyticalisoelectric focusing for detection and identification of /3-lactamases. J Gen Microbiol 1975;88:169-78.
18. Jalakas-Pomull K, Dombusch K, Kuhn I, Ransjo U, Jonsson C, Broberger U. Characterization of /3-lactam-resistant Klebsiella oxytoca isolated in a neonatal intensive care unit. APMIS 1991;99:530-6.
19. Bauemfeind A, Casellas JM, Goldberg M, et al. A new plasmidic cefotaxi-mase from patients infected with Salmonella typhimurium. Infection 1992;20:158-63.
20. Kado CI Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981;145:1365-73.
21. Kacica MA, Horgan MJ, Preston ICE, Lepow M, Venezia RA. Relatedness of coagulase-negative staphylococci causing bacteremia in low-birthweight infants. Infect Control Hosp Epidemiol 1994;15:658-62.
22. Curtiss R III. Gene Transfer. In: Gerhardt P, Murray RG, Costilow RN, et al. eds. Manual of methods for general bacteriology. Washington, DC: American Society for Microbiology, 1981:243-65.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989:1.13.
24. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7.
25. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 1984; 12:387-95.
26. Billot-Klein D, Gutmann L, Collatz E. Nucleotide sequence of the SHV-5 /3-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob Agents Chemother 1990;34:2439-41.
27. Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing /3-lactamases in a single isolate. Antimicrob Agents Chemother 1994;38:761-6.
28. Naumovski L, Quinn JP, Miyashiro D, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum /3-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992;36:1991-6.
29. Bingen EH, Desjardins P, Arlet G, et al. Molecular epidemiology of plasmid spread among extended broad-spectrum /3-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. J Clin Microbiol 1993;31:179-84.
30. Heritage J, Hawkey PM, Todd N, Lewis IJ. Transposition of the geneencoding a TEM-12 extended-spectrum /3-lactamase, Antimicrob Agents Chemother 1992;36:1981-6.
31. Nugent ME, Hedges RW. The nature of the genetic determinant for the SHV-1 /3-lactamase. MGG Mol Gen Genet 1979;175:239-43.
32. Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended-spectrum /3-lactamases. Antimicrob Agents Chemother 1991;35:164-9.
33. Bauemfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients. Infection 1993;21:18-22.
34. Gutmann L, Ferre B, Goldstein FW, et al. SHV-5, a novel SHV-type /3-lactamasc that hydrolyzes broad-spectrum cephalosporins and monobac-tams. Antimicrob Agents Chemother 1989;33:951-6.
35. Shannon KP, King A, Phillips I, Nicolas MH, Philippon A. Importation of organisms producing broad-spectrum SHV-group /3-lactamases into the United Kingdom. J Antimicrob Chemother 1990;25:343-51.
36. Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis N.I. Prevalence of a transferable SHV-5 type /3-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26:635-48.
37. Mulgravc L, Attwood PV. Characterization of an SHV-5 related extended broad-spectrum beta-lactamase in Enterobacteriaceae from Western Australia. Pathology 1993:25:71-5.